14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The kinetics of 18F-FDG in lung cancer: compartmental models and voxel analysis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The validation of the most appropriate compartmental model that describes the kinetics of a specific tracer within a specific tissue is mandatory before estimating quantitative parameters, since the behaviour of a tracer can be different among organs and diseases, as well as between primary tumours and metastases. The aims of our study were to assess which compartmental model better describes the kinetics of 18F-Fluorodeoxygluxose( 18F-FDG) in primary lung cancers and in metastatic lymph nodes; to evaluate whether quantitative parameters, estimated using different innovative technologies, are different between lung cancers and lymph nodes; and to evaluate the intra-tumour inhomogeneity.

          Results

          Twenty-one patients (7 females; 71 ± 9.4 years) with histologically proved lung cancer, prospectively evaluated, underwent 18F-FDG PET-CT for staging. Spectral analysis iterative filter (SAIF) method was used to design the most appropriate compartmental model. Among the compartmental models arranged using the number of compartments suggested by SAIF results, the best one was selected according to Akaike information criterion (AIC). Quantitative analysis was performed at the voxel level. K 1, V b and K i were estimated with three advanced methods: SAIF approach, Patlak analysis and the selected compartmental model. Pearson’s correlation and non-parametric tests were used for statistics. SAIF showed three possible irreversible compartmental models: Tr-1R, Tr-2R and Tr-3R. According to well-known 18F-FDG physiology, the structure of the compartmental models was supposed to be catenary. AIC indicated the Sokoloff’s compartmental model (3K) as the best one. Excellent correlation was found between K i estimated by Patlak and by SAIF ( R 2 = 0.97, R 2 = 0.94, at the global and the voxel level respectively), and between K i estimated by 3K and by SAIF ( R 2 = 0.98, R 2 = 0.95, at the global and the voxel level respectively). Using the 3K model, the lymph nodes showed higher mean and standard deviation of V b than lung cancers ( p < 0.0014, p < 0.0001 respectively) and higher standard deviation of K 1 ( p < 0.005).

          Conclusions

          One-tissue reversible plus one-tissue irreversible compartmental model better describes the kinetics of 18F-FDG in lung cancers, metastatic lymph nodes and normal lung tissues. Quantitative parameters, estimated at the voxel level applying different advanced approaches, show the inhomogeneity of neoplastic tissues. Differences in metabolic activity and in vascularization, highlighted among all cancers and within each individual cancer, confirm the wide variability in lung cancers and metastatic lymph nodes. These findings support the need of a personalization of therapeutic approaches.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: not found
          • Article: not found

          Tumor heterogeneity.

          G. Heppner (1984)
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            SUV: standard uptake or silly useless value?

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

              To understand the genetic basis and clonal evolution underlying metastatic progression of human breast cancer in vivo, we analyzed the genetic composition of 29 primary breast carcinomas and their paired asynchronous metastases by comparative genomic hybridization and fluorescence in situ hybridization. The mean number of genetic changes by comparative genomic hybridization was 8.7 +/- 5.3 in primary tumors and 9.0 +/- 5.7 in their metastases. Although most of the genetic changes occurred equally often in the two groups, gains of the Xq12-q22 region were enriched in the metastases. According to a statistical analysis of shared genetic changes and breakpoints in paired specimens, 20 of the metastases (69%) showed a high degree of clonal relationship with the corresponding primary tumor, whereas the genetic composition of 9 metastases (31%) differed almost completely from that of the paired primary tumors. In both groups, however, chromosome X inactivation patterns suggested that the metastatic lesions originated from the same clone as the primary tumor. Fluorescence in situ hybridization analysis with probes specific to metastatic clones usually failed to find such cells in the primary tumor sample. In conclusion, detailed characterization of the in vivo progression pathways of metastatic breast cancer indicates that a linear progression model is unlikely to account for the progression of primary tumors to metastases. An early stem line clone apparently evolves independently in the primary tumor and its metastasis, eventually leading to multiple, genetically almost completely different, clones in the various tumor locations in a given patient. The resulting heterogeneity of metastatic breast cancer may underlie its poor responsiveness to therapy and explain why biomarkers of prognosis or therapy responsiveness measured exclusively from primary tumors give a restricted view of the biological properties of metastatic breast cancer.
                Bookmark

                Author and article information

                Contributors
                erica.silvestri84@gmail.com
                valentina.scolozzi@gmail.com
                gaia.rizzo@gmail.com
                luca.indovina@policlinicogemelli.it
                marco.castellaro@gmail.com
                mvittoriamattoli@yahoo.it
                p.graziano@operapadrepio.it
                giucardillo@gmail.com
                +39-049-8277694 , alessandra.bertoldo@unipd.it
                marialucia.calcagni@unicatt.it
                Journal
                EJNMMI Res
                EJNMMI Res
                EJNMMI Research
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                2191-219X
                29 August 2018
                29 August 2018
                2018
                : 8
                : 88
                Affiliations
                [1 ]ISNI 0000 0004 1757 3470, GRID grid.5608.b, Department of Information Engineering, , University of Padova, ; Via G. Gradenigo 6/B, 35131 Padova, Italy
                [2 ]ISNI 0000 0001 0941 3192, GRID grid.8142.f, Department of Diagnostic Imaging, Radiation Oncology and Haematology, Institute of Nuclear Medicine, , Fondazione Policlinico Universitario A. Gemelli IRCCS – Università Cattolica del Sacro Cuore, ; Roma, Italy
                [3 ]GRID grid.414603.4, Medical Physics Unit, , Fondazione Policlinico Universitario A. Gemelli IRCCS, ; Roma, Italy
                [4 ]Unit of Pathology, Scientific Institute for Research and Health Care “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Foggia, Italy
                [5 ]ISNI 0000 0004 1805 3485, GRID grid.416308.8, Unit of Thoracic Surgery, , San Camillo Forlanini Hospital, ; Rome, Italy
                Article
                439
                10.1186/s13550-018-0439-8
                6115323
                30159686
                2da3761b-a667-45a5-9957-9076897c88c9
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 5 June 2018
                : 9 August 2018
                Categories
                Original Research
                Custom metadata
                © The Author(s) 2018

                Radiology & Imaging
                Radiology & Imaging

                Comments

                Comment on this article